Teva Women's Health, Inc. v. Lupin, Ltd., No. 12-1577 (Fed. Cir. May 21, 2013)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

TEVA WOMEN'S HEALTH, INC.,

Plaintiff-Appellant,

v.

LUPIN, LTD., AND

LUPIN PHARMACEUTICALS, INC.,

Defendants-Appellees,

AND

MYLAN PHARMACEUTICALS INC., MYLAN INC.,

AND FAMY CARE LTD.,

Defendants-Appellees.

2012-1577

Appeal from the United States District Court for the District of New Jersey in Nos. 10-CV-0603 and 10-CV-1235, Judge Peter G. Sheridan.

JUDGMENT

RICHARD C. PETTUS, Greenberg Traurig LLP, of New York, New York, argued for plaintiff-appellant. With him

2on the brief was CHARANJIT BRAHMA, of Washington, DC. Of counsel were VERA RANIERI, and NICHOLAS A. BROWN of San Francisco, California; and JACK LIN of Washington, DC.

TIMOTHY H. KRATZ, McGuire Woods LLP, of Atlanta, Georgia, argued for defendants-appellees. With him on the brief were ROBERT L. FLORENCE and GEORGE J. BARRY, III. Of counsel on the brief were ARNOLD B. CALMANN, Saiber LLC, of Newark, New Jersey; SAILESH K. PATEL, Schiff Hardin LLP, of Chicago, Illinois; D. CHRISTOPHER OHLY, of Washington, DC; GEORGE C. YU and ALISON L. MADDEFORD, of San Francisco, California; HENRY P. BEHNEN, of New York, New York; and KAREN A. CONFOY and ERICA S. HELMS, Sterns & Weinroth, P.C., of Trenton, New Jersey.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: